Paul Tudor Jones Pulmonx Corp Transaction History
Tudor Investment Corp Et Al
- $26.8 Billion
- Q3 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Pulmonx Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 136,820 shares of LUNG stock, worth $848,284. This represents 0.0% of its overall portfolio holdings.
Number of Shares
136,820
Previous 135,685
0.84%
Holding current value
$848,284
Previous $860,000
31.86%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding LUNG
# of Institutions
124Shares Held
31MCall Options Held
300Put Options Held
204K-
Primecap Management CO Pasadena, CA5.68MShares$35.2 Million0.04% of portfolio
-
Morgan Stanley New York, NY3.79MShares$23.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY2.67MShares$16.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.28MShares$14.1 Million0.0% of portfolio
-
Jefferies Group LLC New York, NY1.2MShares$7.45 Million0.2% of portfolio
About Pulmonx Corp
- Ticker LUNG
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,268,400
- Market Cap $231M
- Description
- Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...